溶瘤病毒在肿瘤免疫原性细胞死亡中的研究进展
DOI:
作者:
作者单位:

河北北方学院

作者简介:

通讯作者:

中图分类号:

基金项目:


Research progress of oncolytic virus in tumor immunogenic cell death
Author:
Affiliation:

Hebei North University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    免疫原性细胞死亡(Immunogenic cell death, ICD)是一种特殊的细胞死亡模式,能够激活免疫系统,尤其是在癌症的治疗当中,ICD能够通过释放一系列损伤相关分子模式(Damage-Associated Molecular Patterns,DAMPs)来增强免疫系统对肿瘤的识别和攻击,从而达到杀伤肿瘤的效果。溶瘤病毒(Oncolytic virus,OV)是一类可以选择性感染并杀死肿瘤细胞,同时保留正常细胞不受损害的病毒。OVs作为Ⅱ型ICD诱导剂通过靶向内质网来诱导肿瘤细胞发生ICD。本综述基于ICD的特征进一步阐述OVs诱导ICD的机制,以及研究较深入的Ⅱ、Ⅲ期临床进展,为未来治疗肿瘤提供一定的思路和参考。

    Abstract:

    Immunogenic cell death (ICD) is a special cell death mode that can activate the immune system, especially in the treatment of cancer. ICD can enhance the recognition and attack of the immune system on tumors by releasing a series of damage associated molecular patterns (DAMPs), so as to achieve the effect of killing tumors. Oncolytic virus (OV) is a kind of virus that can selectively infect and kill tumor cells while preserving normal cells from damage. OVs, as type II ICD inducers, induce ICD in tumor cells by targeting the endoplasmic reticulum. Based on the characteristics of ICD, this review further elaborated the mechanism of ICD induced by OVs and the latest clinical progress, providing some ideas and references for the future treatment of tumors.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-03-07
  • 最后修改日期:2025-06-24
  • 录用日期:2025-09-11
  • 在线发布日期:
  • 出版日期: